VivoSim Labs (0R02) Financial Statements
VivoSim Labs Financial Overview
VivoSim Labs's market cap is currently $2.56M. The company's EPS TTM is $-6.04; its P/E ratio is -0.03; VivoSim Labs has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 131.00K | $ 109.00K | $ 370.00K | $ 1.50M | $ 0.00 |
| Gross Profit | $ 131.00K | $ 109.00K | $ 370.00K | $ 1.50M | $ 0.00 |
| Operating Income | $ -11.22M | $ -15.09M | $ -17.73M | $ -11.48M | $ -16.83M |
| EBITDA | $ -13.35M | $ -14.39M | $ -16.96M | $ -11.30M | $ -13.98M |
| Net Income | $ -13.84M | $ -14.67M | $ -17.26M | $ -11.45M | $ -16.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.02M | $ 2.90M | $ 16.01M | $ 28.68M | $ 37.36M |
| Total Assets | $ 7.39M | $ 6.35M | $ 20.31M | $ 33.30M | $ 39.92M |
| Total Debt | $ 447.00K | $ 1.39M | $ 1.80M | $ 2.18M | $ 0.00 |
| Net Debt | $ -4.58M | $ -1.51M | $ -13.50M | $ -26.49M | $ -37.36M |
| Total Liabilities | $ 8.48M | $ 2.75M | $ 4.98M | $ 3.09M | $ 721.00K |
| Stockholders' Equity | $ -1.10M | $ 3.60M | $ 15.33M | $ 30.21M | $ 39.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.83M | $ -14.70M | $ -12.80M | $ -8.86M | $ -13.73M |
| Operating Cash Flow | $ -10.83M | $ -14.65M | $ -12.41M | $ -8.45M | $ -13.32M |
| Investing Cash Flow | $ 94.00K | $ 816.00K | $ -966.00K | $ -409.00K | $ -393.00K |
| Financing Cash Flow | $ 4.45M | $ 1.44M | $ 0.00 | $ 205.00K | $ 23.84M |
Currency in USD
